Monoclonal Antibody Cocktail Authorized for Post-COVID Exposure

(MedPage Today) -- FDA expanded the emergency use authorization (EUA) for the monoclonal antibody cocktail casirivimab and imdevimab, to include post-exposure prophylaxis (PEP) among certain people exposed to COVID-19, manufacturer Regeneron announced...